A peer-reviewed journal that offers evidence-based clinical information and continuing education for dentists.

Johnson & Johnson Seeks Approval for COVID-19 Booster Shot


United States pharmaceutical giant Johnson & Johnson (J&J) has requested approval from the US Food and Drug Administration (FDA) to allow booster shots of its one-dose COVID-19 to be administered to millions of Americans. J&J’s application asks for the booster shot to be made available to individuals age 18 and older who received an initial dose of the vaccine. The company submitted data on booster intervals from 2 months to 6 months following the initial dose. The FDA is scheduled to review J&J’s request on October 15. Click here to read more.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy